Outsourcing in Discovery Chemistry Strategy Selection Success
Hansjoerg Lehmann, Novartis Pharma AG, speaking at Discovery Chemistry Congress 2012.
Outsourcing Chemical Synthesis in the Drug Discovery Process
Gunter Festel, Autodisplay Biotech, speaking at Discovery Chemistry Congress 2012
The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain Pathologies
Professor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.
Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory Enhancement
Dr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.
Smooth Muscle Kv7 (KCNQ) Potassium Channels: Important New Therapeutic Targets
Professor Kenneth Byron, Loyola University Chigaco, speaking at Ion Channel Targets 2011.
Protons, Heat and Mechanical Force Converge to Gate Two-Pore Potassium Channels at the Selectivity Filter
Dr Slav Bagriantsev, University of California, speaking at Ion Channel Targets 2011.
Patent Pheromones: Attracting Money, Repelling Infringement, Prompting a Mating Response
Thomas Saunders, Of Counsel, Rissman Hendricks & Oliverio, speaking at Medchem Europe 2011.
Latent Hit Identification in Primary Screening Data with Compound Set Enrichment
Thibault Varin, PostDoctoral Fellow, Novartis, Speaking at Medchem Europe 2011.
Current Perspectives in Fragment Based Ligand Discovery
Roderick Hubbard, Professor, University of York, speaking at Medchem Europe 2011